Krinner Axel, Schultze Michael, Marijam Alen, Pignot Marc, Kossack Nils, Mitrani-Gold Fanny S, Joshi Ashish V
WIG2 GmbH Scientific Institute for Health Economics and Health System Research, Leipzig, Germany.
ZEG - Berlin Center for Epidemiology and Health Research GmbH, Berlin, Germany.
Infect Dis Ther. 2024 Jul;13(7):1487-1500. doi: 10.1007/s40121-024-00973-8. Epub 2024 Jun 13.
Understanding antibiotic prescribing for uncomplicated urinary tract infection (uUTI) could help to optimize management. However, data on uUTI treatment patterns in the European Union are scarce. We used real-world data to evaluate adherence to antibiotic prescribing guidelines for femalepatients with uUTI in Germany.
This retrospective cohort study used anonymized German statutory health insurance claims data from the Wissenschaftliches Institut für Gesundheitsökonomie und Gesundheitssystemforschung from January 2013 to December 2019. Patients were female, aged ≥ 12 years, with an index uUTI diagnosis. Patient characteristics and treating physician specialties were examined overall and in sub-cohorts for recommended/non-recommended treatment (based on initial therapy adherence to German uUTI treatment guidelines) and optimal/sub-optimal outcome (based on a prescription of different antibiotics or a urinary tract infection-related episode).
Overall, 144,645 uUTI cases in 124,971 patients were analyzed; 51,230 (35.4%) and 93,415 (64.6%) cases were assigned to the recommended/non-recommended treatment sub-cohorts, respectively. Clinically meaningful differences in age and comorbidities were observed between these sub-cohorts. Most cases had an optimal outcome (n = 122,823; 84.9%); of these, a higher proportion received antibiotics that were recommended but not as first-choice versus first-choice therapies as their initial treatment (58.6% vs. 35.3%). In the sub-optimal outcome cohort, 49.1% received antibiotics that were recommended but not as first-choice and 41.1% received first-choice therapies as their initial treatment. Most uUTIs were treated by general practitioners (GPs; 82.3%), followed by gynecologists (13.3%), and urologists (6.8%). Notably, 64.5% of initial therapy prescriptions filled by gynecologists and 32.1% by GPs were first-choice antibiotics.
A high proportion of prescribed treatments for the initial uUTI episode were not recommended by German uUTI guidelines as first-choice antibiotics. Prescribing adherence varied by physician specialty; specialists showed greater adherence to treatment guidelines versus GPs. This study provides a novel and multi-dimensional picture of uUTI treatment in Germany.
了解单纯性尿路感染(uUTI)的抗生素处方情况有助于优化治疗管理。然而,欧盟关于uUTI治疗模式的数据匮乏。我们使用真实世界数据评估德国女性uUTI患者对抗生素处方指南的依从性。
这项回顾性队列研究使用了来自健康经济与卫生系统研究科学研究所的2013年1月至2019年12月德国法定医疗保险匿名理赔数据。患者为年龄≥12岁的女性,有首次uUTI诊断。总体及在亚队列中检查了患者特征和治疗医生的专业,亚队列按推荐/不推荐治疗(基于初始治疗对德国uUTI治疗指南的依从性)和最佳/次优结局(基于不同抗生素的处方或尿路感染相关发作)划分。
总体上,分析了124,971名患者的144,645例uUTI病例;分别有51,230例(35.4%)和93,415例(64.6%)病例被归入推荐/不推荐治疗亚队列。这些亚队列在年龄和合并症方面观察到具有临床意义的差异。大多数病例有最佳结局(n = 122,823;84.9%);其中,较高比例的患者接受的抗生素是推荐但非首选的,而不是将首选疗法作为初始治疗(58.6%对35.3%)。在次优结局队列中,49.1%的患者接受的抗生素是推荐但非首选的,41.1%的患者将首选疗法作为初始治疗。大多数uUTI由全科医生(GP;82.3%)治疗,其次是妇科医生(13.3%)和泌尿科医生(6.8%)。值得注意的是,妇科医生开出的初始治疗处方中有64.5%是首选抗生素,全科医生开出的处方中有32.1%是首选抗生素。
德国uUTI指南不推荐将高比例的初始uUTI发作处方治疗作为首选抗生素。处方依从性因医生专业而异;专科医生比全科医生对治疗指南的依从性更高。本研究提供了德国uUTI治疗的全新多维度情况。